Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Exp Med ; 214(2): 327-338, 2017 02.
Article in English | MEDLINE | ID: mdl-28082358

ABSTRACT

Dendritic cells are targeted by regulatory T (T reg) cells, in a manner that operates as an indirect mode of T cell suppression. In this study, using a combination of single-cell force spectroscopy and structured illumination microscopy, we analyze individual T reg cell-DC interaction events and show that T reg cells exhibit strong intrinsic adhesiveness to DCs. This increased DC adhesion reduces the ability of contacted DCs to engage other antigen-specific cells. We show that this unusually strong LFA-1-dependent adhesiveness of T reg cells is caused in part by their low calpain activities, which normally release integrin-cytoskeleton linkage, and thereby reduce adhesion. Super resolution imaging reveals that such T reg cell adhesion causes sequestration of Fascin-1, an actin-bundling protein essential for immunological synapse formation, and skews Fascin-1-dependent actin polarization in DCs toward the T reg cell adhesion zone. Although it is reversible upon T reg cell disengagement, this sequestration of essential cytoskeletal components causes a lethargic state of DCs, leading to reduced T cell priming. Our results reveal a dynamic cytoskeletal component underlying T reg cell-mediated DC suppression in a contact-dependent manner.


Subject(s)
Cell Communication , Cell Polarity , Cytoskeleton/physiology , Dendritic Cells/physiology , T-Lymphocytes, Regulatory/physiology , Animals , Cell Adhesion , Cells, Cultured , Lymphocyte Function-Associated Antigen-1/physiology , Mice , Mice, Inbred C57BL , Microfilament Proteins/physiology , Receptors, Odorant/physiology , T-Lymphocytes, Regulatory/cytology
2.
J Immunol ; 186(12): 6798-806, 2011 Jun 15.
Article in English | MEDLINE | ID: mdl-21593382

ABSTRACT

Adenosine has been established as an important regulator of immune activation. It signals through P1 adenosine receptors to suppress activation of T cells and professional APCs. Adenosine deaminase (ADA) counters this effect by catabolizing adenosine. This regulatory mechanism has not been tested in a disease model in vivo. Questions also remain as to which cell types are most sensitive to this regulation and whether its dysregulation contributes to any autoimmune conditions. We approached this issue using the NOD model. We report that ADA is upregulated in NOD dendritic cells, which results in their exuberant and spontaneous activation. This, in turn, triggers autoimmune T cell activation. NOD DCs deficient in ADA expression have a greatly reduced capacity to trigger type I diabetes. We also provide evidence that although many cell types, particularly T cells, have been implicated as the suppression targets by adenosine in an in vitro setting, DCs also seem to be affected by this regulatory mechanism. Therefore, this report illustrates a role of ADA in autoimmunity and suggests a potential target for therapeutic intervention.


Subject(s)
Adenosine Deaminase/immunology , Autoimmunity/immunology , Dendritic Cells/enzymology , Diabetes Mellitus/immunology , Lymphocyte Activation , T-Lymphocytes/immunology , Adenosine Deaminase/analysis , Animals , Dendritic Cells/immunology , Diabetes Mellitus/etiology , Mice , Mice, Inbred NOD
3.
Nat Med ; 17(4): 479-87, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21399646

ABSTRACT

As an approved vaccine adjuvant for use in humans, alum has vast health implications, but, as it is a crystal, questions remain regarding its mechanism. Furthermore, little is known about the target cells, receptors, and signaling pathways engaged by alum. Here we report that, independent of inflammasome and membrane proteins, alum binds dendritic cell (DC) plasma membrane lipids with substantial force. Subsequent lipid sorting activates an abortive phagocytic response that leads to antigen uptake. Such activated DCs, without further association with alum, show high affinity and stable binding with CD4(+) T cells via the adhesion molecules intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1). We propose that alum triggers DC responses by altering membrane lipid structures. This study therefore suggests an unexpected mechanism for how this crystalline structure interacts with the immune system and how the DC plasma membrane may behave as a general sensor for solid structures.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Alum Compounds/administration & dosage , Dendritic Cells/immunology , Dendritic Cells/metabolism , Membrane Lipids/immunology , Membrane Lipids/metabolism , Adjuvants, Immunologic/pharmacokinetics , Alum Compounds/pharmacokinetics , CD4-Positive T-Lymphocytes/immunology , Cell Line , Dendritic Cells/drug effects , Dendritic Cells/ultrastructure , Enzyme Activation/drug effects , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Microscopy, Electron, Scanning , Models, Immunological , Phagocytosis/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Signal Transduction/immunology , Syk Kinase , Vaccines/administration & dosage
4.
Immunol Rev ; 233(1): 203-17, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20193001

ABSTRACT

Uric acid crystals [monosodium urate (MSU)] have emerged as an important factor for both gouty arthritis and immune regulation. This simple crystalline structure appears to activate innate host defense mechanisms in multiple ways and triggers robust inflammation and immune activation. The recognition mechanisms of MSU following its phase change from soluble uric acid are diverse, involving both protein receptors and non-specific plasma membrane attachment. Upon contact with host cells, MSU induces a set of membrane events that trigger Syk and PI3K activation, phagocytosis, and cytokine production. Having entered the cell, MSU further triggers NALP3 inflammasome activation and induces the production of IL-1 beta, likely inducing a full spectrum of inflammation. This review describes the recognition mechanisms and activation pathways involved in MSU-mediated inflammation and adjuvanticity and hypothesizes that direct membrane binding by solid surfaces, such as MSU, may function as a generic mechanism in tissue responses to particulate and crystalline structures.


Subject(s)
Arthritis, Gouty/immunology , Immunity, Innate , Inflammation Mediators/immunology , Signal Transduction/immunology , Uric Acid/immunology , Animals , Arthritis, Gouty/therapy , Crystallization , Humans
5.
Eur J Immunol ; 40(2): 449-59, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19950175

ABSTRACT

Adenosine has long been regarded as a crucial anti-inflammatory agent that protects the host from excessive damage. It has been reported to play an important role in suppressing immune activation, particularly that of T cells. However, it is a general observation that induction of T-cell activation is an efficient event despite the high adenosine levels that are often present in the affected host due to injury or stress. We report here that prior to antigenic stimulation via TCR/CD3, exposure of T cells to adenosine desensitizes adenosine receptors, so as to create a window of time where the T cells are insensitive to this ubiquitous suppressor. T cells from mice that were pre-exposed to this manipulation showed stronger responses to antigenic stimulation; therefore, the P1 adenosine receptor desensitization demonstrated an adjuvant-like effect. Our results suggest that adenosine receptor desensitization may be a mechanism for T cells to escape the general suppression during early points of T-cell activation and may emerge as a potential alternative for vaccine adjuvants.


Subject(s)
Adenosine/pharmacology , Cyclic AMP/metabolism , Signal Transduction/drug effects , T-Lymphocytes/drug effects , Adenosine/analogs & derivatives , Adenosine A1 Receptor Agonists , Adenosine A1 Receptor Antagonists , Adenosine A2 Receptor Agonists , Adenosine A2 Receptor Antagonists , Adenosine-5'-(N-ethylcarboxamide)/pharmacology , Animals , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/metabolism , Cells, Cultured , Lymphocyte Activation/drug effects , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Receptor, Adenosine A1/genetics , Receptor, Adenosine A2A/genetics , Reverse Transcriptase Polymerase Chain Reaction , Spleen/cytology , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Xanthines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...